Andrew Reinland just Unloaded 1,995 shares of F5 Networks, Inc. (FFIV), be careful if you are long!; Dova Pharmaceuticals (DOVA) Shorts Raised By 5.75%

Based on an average price-per-share of $144.8, Andrew Reinland, the F5 Networks Inc’s EVP – Chief Financial Officer sold 1,995 shares of F5 Networks Inc worth exactly $288,933 U.S Dollars. Currently, he possess a total of 17,853 shares or 0.03% of the company’s total market capitalization.

Dova Pharmaceuticals Incorporated (NASDAQ:DOVA) had an increase of 5.75% in short interest. DOVA’s SI was 2.62 million shares in February as released by FINRA. Its up 5.75% from 2.47M shares previously. With 46,300 avg volume, 57 days are for Dova Pharmaceuticals Incorporated (NASDAQ:DOVA)’s short sellers to cover DOVA’s short positions. The stock increased 0.81% or $0.25 during the last trading session, reaching $30.99. About 17,580 shares traded. Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) has 0.00% since February 5, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 37 analysts covering F5 Networks Inc. (NASDAQ:FFIV), 8 have Buy rating, 1 Sell and 28 Hold. Therefore 22% are positive. F5 Networks Inc. has $168 highest and $90.0 lowest target. $129.30’s average target is -8.37% below currents $141.11 stock price. F5 Networks Inc. had 106 analyst reports since July 24, 2015 according to SRatingsIntel. Barclays Capital maintained F5 Networks, Inc. (NASDAQ:FFIV) on Thursday, July 27 with “Overweight” rating. Cowen & Co maintained it with “Buy” rating and $162.0 target in Thursday, January 25 report. Pacific Crest downgraded the stock to “Sector Weight” rating in Tuesday, May 17 report. The rating was downgraded by Sterne Agee CRT to “Neutral” on Friday, January 15. The company was maintained on Thursday, October 26 by Barclays Capital. The firm has “Neutral” rating by Buckingham Research given on Monday, August 3. The firm has “Buy” rating by DA Davidson given on Friday, August 12. The rating was maintained by Drexel Hamilton on Thursday, July 27 with “Buy”. The firm has “Hold” rating given on Thursday, July 27 by Robert W. Baird. The firm has “Hold” rating given on Tuesday, January 23 by RBC Capital Markets.

F5 Networks, Inc. develops, markets, and sells application delivery networking products that optimize the security, performance, and availability of network applications, servers, and storage systems. The company has market cap of $8.73 billion. The company's primary application delivery technology is Traffic Management Operating System that enable company's products to intercept, inspect, and act on the contents of traffic from virtually each type of Internet Protocol-enabled application. It has a 21.78 P/E ratio. It offers Local Traffic Manager, which provides intelligent load-balancing, traffic management, and application health checking; BIG-IP DNS that automatically directs users to the closest or best-performing physical, virtual, or cloud environment; Advanced Firewall Manager, a network firewall; and Application Security Manager, an Web application firewall that provides comprehensive, proactive, and application-layer protection against generalized and targeted attacks.

The stock decreased 2.10% or $3.02 during the last trading session, reaching $141.11. About 663,198 shares traded. F5 Networks, Inc. (NASDAQ:FFIV) has risen 21.28% since February 5, 2017 and is uptrending. It has outperformed by 4.58% the S&P500.

Since September 5, 2017, it had 0 insider buys, and 1 insider sale for $382,480 activity. 3,262 shares were sold by Gibson Benjamin, worth $382,480 on Tuesday, September 5.

Investors sentiment decreased to 0.84 in Q3 2017. Its down 0.15, from 0.99 in 2017Q2. It turned negative, as 42 investors sold F5 Networks, Inc. shares while 168 reduced holdings. 32 funds opened positions while 144 raised stakes. 60.06 million shares or 0.69% less from 60.48 million shares in 2017Q2 were reported. Texas Permanent School Fund owns 17,611 shares or 0.03% of their US portfolio. Guardian Life Insurance Of America invested in 146 shares. Bridgewater Assocs Lp holds 0.01% or 6,974 shares. Asset Inc owns 17,385 shares. Cordasco Fincl Networks stated it has 2,000 shares or 0.26% of all its holdings. Alps Advsr Inc reported 0% of its portfolio in F5 Networks, Inc. (NASDAQ:FFIV). Pnc Ser Group Inc owns 5,468 shares for 0% of their portfolio. Wells Fargo And Com Mn holds 0.01% or 323,136 shares in its portfolio. Moreover, Cs Mckee L P has 1.49% invested in F5 Networks, Inc. (NASDAQ:FFIV) for 159,800 shares. Renaissance Group reported 242,682 shares stake. Asset Mgmt One Communication Limited holds 0.03% or 107,509 shares in its portfolio. Fund Mgmt Sa invested in 0.09% or 107,412 shares. Cadence Management Ltd Limited Liability Company reported 1,997 shares. 18,946 were accumulated by Amer. Bnp Paribas Asset Holding reported 116,426 shares stake.

Dova Pharmaceuticals, Inc., a pharmaceutical company, focuses on acquiring, developing, and commercializing drug candidates for thrombocytopenia diseases. The company has market cap of $794.97 million. The Company’s drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist that has completed Phase III clinical trials for the treatment of thrombocytopenia in patients with chronic liver diseases. It currently has negative earnings.